Weekly subcutaneous erythropoietin maintains hematocrit in chronic hemodialysis patients.
Parker
K P
KP
Department of Medicine, Atlanta Veterans Affairs Medical Center, Decatur, GA.
Sands
J M
JM
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage* / Q000494:pharmacology; D006400:Hematocrit; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000494:pharmacology; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D006435:Renal Dialysis
D007155:Immunologic Factors; D011994:Recombinant Proteins; D004921:Erythropoietin